Investigators said patients experienced adverse effects in line with those expected for myeloablative conditioning with ...

While name brands like Adderall and Vyvanse may have been recently removed from the FDA Drug Shortage Database, it's unclear ...

Bhattacharya's nomination, alongside Robert F. Kennedy Jr. and Mehmet Oz, indicates potential shifts in vaccine policy under ...

The single-center report showed the therapy had a favorable safety profile and manageable side effects in children with ...

Patients with amblyopia had a statistically significant improvement in their visual acuity after binocular rehabilitation ...

Accompanying these findings is a call for refined treatment strategies that have potential to better outcomes among patients ...

A review of recent clinical trial results for emerging HER2-directed therapies, including SOHO-01, inetetamab/pyrotinib, and ...

The authors emphasize the value of subgroup analyses for tracking patterns in spinal muscular atrophy (SMA), as opposed to ...

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing ...

Antifibrotic treatment rates for IPF differ significantly between referral hospitals and general hospitals or clinics, with ...

Real-world outcomes for HER2-positive NSCLC differ from clinical trials due to diverse patient populations and treatment ...

An exploration of emerging strategies to overcome resistance to HER2-directed therapies based on ongoing research advancements.